Inovio Pharmaceuticals
INO
#9222
Rank
โ‚น9.54 B
Marketcap
โ‚น138.87
Share price
-1.28%
Change (1 day)
-15.20%
Change (1 year)

Inovio Pharmaceuticals (INO) - P/B ratio

P/B ratio as of January 2026 : -13.7

According to Inovio Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 580.262.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Inovio Pharmaceuticals - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31-20.4-2168.06%
2024-12-310.9854-16.94%
2023-12-311.19-32.22%
2022-12-311.75-33.37%
2021-12-312.63-19.21%
2020-12-313.25-94.75%
2019-12-3161.91284.97%
2018-12-314.4770.73%
2017-12-312.62-37.18%
2016-12-314.1751.02%
2015-12-312.76-44.82%
2014-12-315.00-56.64%
2013-12-3111.5457.47%
2012-12-312.0781.71%
2011-12-311.14-55.62%
2010-12-312.5633.96%
2009-12-311.9159.82%
2008-12-311.20-7.77%
2007-12-311.30-73.97%
2006-12-314.9975.05%
2005-12-312.85-38.94%
2004-12-314.67-11.77%
2003-12-315.2939.65%
2002-12-313.79

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.54-111.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.37-146.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
18.3-233.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.08-144.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
5.25-138.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
4.81-135.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
7.09-151.73%๐Ÿ‡บ๐Ÿ‡ธ USA